Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (IMLFF)

Inmed Pharmaceuticals Inc (IMLFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1710 +8.77%
on 11/25/19
0.2400 -22.50%
on 12/09/19
-0.0395 (-17.52%)
since 11/11/19
3-Month
0.1710 +8.77%
on 11/25/19
0.2940 -36.73%
on 09/12/19
-0.1105 (-37.27%)
since 09/11/19
52-Week
0.1648 +12.86%
on 08/27/19
0.6270 -70.33%
on 02/05/19
-0.1472 (-44.18%)
since 12/11/18

Most Recent Stories

More News
Global OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing

NEW YORK , Dec. 9, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 4 th and...

SOLVY : 11.3800 (-0.70%)
TSCHY : 48.4900 (-7.73%)
ALVOF : 0.5000 (unch)
ARHH : 1.2105 (+0.21%)
BBBXF : 0.1489 (+2.69%)
BCEKF : 2.0419 (-0.11%)
BOSSY : 9.3900 (+0.11%)
CTEQF : 0.1440 (+2.86%)
DYLLF : 0.1850 (-2.63%)
FFNTF : 0.4455 (+2.58%)
GBTC : 8.6200 (-0.35%)
GENTF : 9.3500 (-31.00%)
GLATF : 0.3550 (-3.53%)
GLGDF : 0.4667 (-2.36%)
IMLFF : 0.1860 (-4.47%)
JUSHF : 1.1350 (+2.25%)
MDRPF : 0.4650 (+9.90%)
MHGU : 19.0500 (+0.26%)
MHGUP : 35.6500 (unch)
NMGRF : 0.1569 (+2.89%)
RHNMF : 0.1660 (-2.92%)
SGSVF : 1.4500 (+1.05%)
SVYSF : 112.4398 (-0.53%)
TNYBF : 0.2887 (-5.75%)
VQSLD : 1.6945 (-1.21%)
XEBEF : 1.6700 (+1.84%)
GGD.TO : 0.63 (unch)
GLO.TO : 0.47 (-4.08%)
MAX.TO : 0.62 (+10.71%)
SBB.TO : 1.90 (+0.53%)
ALV.VN : 0.670 (-2.90%)
BBB.VN : 0.195 (unch)
BCM.VN : 2.700 (unch)
NOU.VN : 0.200 (unch)
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical...

IMLFF : 0.1860 (-4.47%)
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa

VANCOUVER , Dec. 9, 2019 /PRNewswire/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based...

IMLFF : 0.1860 (-4.47%)
IN.TO : 0.24 (-4.00%)
Live Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th

NEW YORK , Dec. 2, 2019 /PRNewswire/ -- /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference...

ALVOF : 0.5000 (unch)
ARHH : 1.2105 (+0.21%)
BBBXF : 0.1489 (+2.69%)
BCEKF : 2.0419 (-0.11%)
BOSSY : 9.3900 (+0.11%)
CTEQF : 0.1440 (+2.86%)
DYLLF : 0.1850 (-2.63%)
FFNTF : 0.4455 (+2.58%)
GBTC : 8.6200 (-0.35%)
GENTF : 9.3500 (-31.00%)
GLATF : 0.3550 (-3.53%)
GLGDF : 0.4667 (-2.36%)
IMLFF : 0.1860 (-4.47%)
JUSHF : 1.1350 (+2.25%)
MDRPF : 0.4650 (+9.90%)
MHGU : 19.0500 (+0.26%)
MHGUP : 35.6500 (unch)
NMGRF : 0.1569 (+2.89%)
RHNMF : 0.1660 (-2.92%)
SGSVF : 1.4500 (+1.05%)
SOLVY : 11.3800 (-0.70%)
TNYBF : 0.2887 (-5.75%)
TSCHY : 48.4900 (-7.73%)
VQSLF : 0.0853 (+6.63%)
XEBEF : 1.6700 (+1.84%)
Live Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th

NEW YORK , Nov. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series....

ALVOF : 0.5000 (unch)
ARHH : 1.2105 (+0.21%)
AUSAF : 0.3400 (-2.69%)
BBBXF : 0.1489 (+2.69%)
BCEKF : 2.0419 (-0.11%)
BOSSY : 9.3900 (+0.11%)
CTEQF : 0.1440 (+2.86%)
DYLLF : 0.1850 (-2.63%)
FFNTF : 0.4455 (+2.58%)
GBTC : 8.6200 (-0.35%)
GENTF : 9.3500 (-31.00%)
GLATF : 0.3550 (-3.53%)
GLGDF : 0.4667 (-2.36%)
GTBDF : 5.8221 (+0.55%)
HEINY : 53.0200 (+0.42%)
IMLFF : 0.1860 (-4.47%)
JUSHF : 1.1350 (+2.25%)
MDRPF : 0.4650 (+9.90%)
MHGU : 19.0500 (+0.26%)
MHGUP : 35.6500 (unch)
OTCM : 34.5000 (+0.21%)
REPYY : 15.8700 (+0.25%)
RHNMF : 0.1660 (-2.92%)
SGSVF : 1.4500 (+1.05%)
SOLVY : 11.3800 (-0.70%)
TNYBF : 0.2887 (-5.75%)
TSCHY : 48.4900 (-7.73%)
VQSLF : 0.0853 (+6.63%)
Edison issues update on InMed Pharmaceuticals

LONDON, UK / ACCESSWIRE / November 18, 2019 / InMed Pharmaceuticals (TSX:IN) recently announced that it filed a Clinical Trial Application in the Netherlands for INM-755, which is being developed for epidermolysis...

IMLFF : 0.1860 (-4.47%)
IN.TO : 0.24 (-4.00%)
InMed Pharmaceuticals to Present at the Cowen Conference

InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade...

IMLFF : 0.1860 (-4.47%)
InMed Pharmaceuticals to Present at the Cowen Conference

VANCOUVER , Nov. 11, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing...

IMLFF : 0.1860 (-4.47%)
IN.TO : 0.24 (-4.00%)
InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade...

IMLFF : 0.1860 (-4.47%)
InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

VANCOUVER , Nov. 8, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing...

IMLFF : 0.1860 (-4.47%)
IN.TO : 0.24 (-4.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IMLFF with:

Key Turning Points

2nd Resistance Point 0.2134
1st Resistance Point 0.2041
Last Price 0.1860
1st Support Level 0.1877
2nd Support Level 0.1806

See More

52-Week High 0.6270
Fibonacci 61.8% 0.4504
Fibonacci 50% 0.3959
Fibonacci 38.2% 0.3414
Last Price 0.1860
52-Week Low 0.1648

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar